drugset / Trial / NCT07182864

MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

NCT07182864 ↗

Phase 1/2 Completed 160 enrolled Minghui Pharmaceutical (Hangzhou) Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Phase I/II Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis.

Timeline

Start
2022-01-06
Primary completion
2022-09-08
Completion
2022-10-08

Drugs

EvaluationDrugModalityDoseRoute
Subject MH004 Unknown 0.1 % Topical
Subject MH004 Unknown 0.3 % Topical
Subject MH004 Unknown 1 % Topical
Subject MH004 Unknown 3 % Topical

Indications